Thiazolidinedione effects on glucocorticoid receptor-mediated gene transcription and differentiation in osteoblastic cells

Endocrinology

Volumn 140, Issue 7, 1999, Pages 3245-3254

  Johnson, Timothy E ^a   Vogel, Robert ^a   Rutledge, Su Jane ^a   Rodan, Gideon ^a   Schmidt, Azriel ^a  

^a MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DEXAMETHASONE; FATTY ACID BINDING PROTEIN; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR; THIAZOLIDINE DERIVATIVE;

ADIPOCYTE; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CALVARIA; CELL DIFFERENTIATION; GENETIC TRANSCRIPTION; MESENCHYME; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOSARCOMA; PRIORITY JOURNAL; STROMA CELL;

EID: 0033305164     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.140.7.6797     Document Type: Article

References (55)

1. Mesenchymal stem cells: Progenitors, progeny, and pathways
2. Glucocorticoids promote development of the osteoblast phenotype by selectively modulating expression of cell growth and differentiation associated genes
3. Glucocorticoid modulation of cell proliferation in cultured osteoblast-like bone cells: Differences between rat and mouse
4. Dexamethasone induces proliferation and terminal differentiation of osteogenic cells in tissue culture
5. Opposing influences of glucocorticoid and retinoic acid on transcriptional control in preosteoblasts
6. Glucocorticoid-induced osteoporosis: Both in vivo and in vitro concentrations of glucocorticoids higher than physiological levels attenuate osteoblast differentiation
7. Peroxisome proliferator-activated receptors: A nuclear receptor signaling pathway in lipid physiology
8. The PPARα-leukotriene B4 pathway to inflammation control
9. Hypolipodemic drugs, polyunsaturated fatty acids, and eicosanoids are ligands for peroxisome proliferator-activated receptors α and δ
10. Fatty acids and eicosanoids regulate gene expression through direct interactions with peroxisome proliferator-activated receptors alpha and gamma
11. Peroxisome proliferator-activated receptors α and γ are activated by indomethacin and other non-steroidal anti-inflammotory drugs
12. Expression of peroxisome proliferator-activated receptors in rat bone
13. Evidence for an inverse relationship between the differentiation of adipocytic and osteogenic cells in rat marrow stromal cell cultures
14. Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor
15. Differential activation of peroxisome proliferator-activated receptors by eicosanoids
16. 15-Deoxy-δ-12,14-prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ
17. High fatty acid content in rabbit serum is responsible for the differentiation of osteoblasts into adipocyte-like cells
18. Regulation of the peroxisome proliferator-activated receptor α gene by glucocorticoids
19. Dexamethasone and insulin demonstrate marked and opposite regulation of the steady-state mRNA level of the peroxisomal proliferator-activated receptor (PPAR) in hepatic cells. Hormonal modulation of fatty-acid-induced transcription
20. Expression of the peroxisome proliferator-activated receptor α gene is stimulated by stress and follows a diurnal rhythm
21. Characterization of a human osteosarcoma cell line (Saos-2) with osteoblastic properties
22. 2, and prostacylclin
23. Identification of a new member of the steroid hormone receptor superfamily that is activated by a peroxisome proliferator and fatty acids
24. 2 in osteoblast cells
25. Differentiation of human bone marrow osteogenic stomal cells in vitro: Induction of the osteoblast phenotype by dexamethosone
26. Construction of DNA sequences complementary to rat 1 and α2 collagen mRNA and their use in studying regulation of type I collagen synthesis by 1,25-dihydroxyvitamin D
27. mPPARγ2: Tissue-specific regulator of an adipocyte enhancer
28. Structure and expression of rat osteosarcoma (ROS 17/2.8) alkaline phosphatase: Product of a single copy gene
29. Mineralized bone nodules formed in vitro from enzymaticany released rat calvaria Cell populations
30. Isolation and characterization of highly enriched, perfusion mouse osteoclastic cells
31. Structural requirements and cell-type specificity for ligand activation of peroxisome proliferator activated receptors
32. The hormone-binding domains of the estrogen and glucocorticoid receptors contain an inducible transcription activation function
33. Functional antagonism between oncoprotein c-Jun and the glucocorticoid receptor
34. Characterization of an NF-1/CTF family member as a functional activator of the mouse mammary tumor virus long terminal repeat 5' enhancer
35. The 5' enhancer of the mouse mammary tumor virus long terminal repeat contains a functional AP-2 element
36. Two independent pathways for transcription from the MMTV promoter
37. Expression of bone matrix proteins during dexamethasone-induced mineralization of human bone marrow stromal cells
38. Osteoblast and chondroblast differentiation
39. Peroxisome proliferator-activated receptor-γ activation by thiazolidinediones induces adipogenesis in bone marrow stromal cells
40. Unsaturated fatty acids synergistically enhance glucocorticoid-induced gene expression
41. Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells
42. Bone formation in vitro by stromal cells obtained from bone marrow of young adult rats
43. 3-induced inhibition of bone nodule formation in long-term cultures of fetal rat calvaria cells
44. Nuclear receptor/AP-1 interaction
45. PPAR-gamma agonists inhibit production of monocyte inflammatory cytokines
46. The peroxisome proliferator-activated receptor-γ is a negative regulator of macrophage activation
47. Modulation of cell signaling pathways can enhance or impair glucocorticoid-induced gene expression without altering the state of receptor phosphorylation
48. The coupling of multiple signal transduction pathways with steroid response mechanisms
49. Steroid hormone receptor status defines the MMTV promoter chromatin structure in vivo
50. Glucocorticoids repress induction by thiazolidinediones, fibrates and fatty acids of phosphoenolpyruvate carboxykinase gene expression in adipocytes
51. Composite element binding the vitamin D receptor, retinoid X receptor α, and a member of the CTF/NF-1 family of transcription factors mediates the vitamin D responsiveness of the c-fos promoter
52. Transcriptional cross-talk, the second mode of steroid hormone receptor action
53. Targets of activated steroid hormone receptors: Basal transcription factors and receptor interacting proteins
54. Dexamethasone potentiates the stimulatory effect of insulin-like growth factor-I on collagen production in cultured human fibroblasts
55. Insulin and dexamethasone regulate insulin receptors, insulin receptor substrate-1, and phosphatidylinositol 3-kinase in Fao hepatoma cells